Peter Attia· MD
and now we have better assay we don't have uh we don't have like optimal assays now but uh these these problems most of these problems have been solved
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and now we have better assay we don't have uh we don't have like optimal assays now but uh these these problems most of these problems have been solved
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
these the assays that were used they were overestimating uh the uh isoform size that was bigger and they were underestimating the small lpa isoform size which is associated with uh with high lpa
these the assays that were used they were overestimating uh the uh isopor size that was bigger and they were underestimating the uh small uh LPA isopor size which is associated with uh with high LPA